A common point of opposition to offering buprenorphine in correctional settings is the perceived risk of diversion, disciplinary issues, or safety concerns created by allowing access to buprenorphine.
Vital Strategies supported technical assistance to six county jails in Pennsylvania that had been funded by the Commonwealth to expand access to buprenorphine to incarcerated persons.
This snapshot looks at the reported incidence of diversion, assault, and conduct citations at the six jails in Pennsylvania that together provided buprenorphine to more than 1,000 individuals over an 18 month period through this state-funded grant program.
Recent Abstracts
Effects of Heat on Early Childhood Development
Sportswashing through Media: Coca-Cola’s Olympic Play – A Research Report
Mais Dados Mais Saúde: Experiência De Discriminação Cotidiana Pela População Brasileira
What’s in Our Food?
Mais Dados Mais Saúde
Monitoramento de Estratégias pelo Fim da Violência contra Crianças e Adolescentes
The Power of Storytelling: Guidance for the Creation of Testimonials
Lead Poisoning and Early Childhood Development
Prioritizing Evidence Gaps: Air Pollution and Health Impacts of Climate Action
Raising Alcohol Taxes to Reduce Harm: Fact Sheets for Brazil